搜索优化
English
全部
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
房地产
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
过去 30 天
时间不限
过去 1 小时
过去 24 小时
过去 7 天
按时间排序
按相关度排序
Onlymyhealth
5 小时
What Does A Headache On The Right Side Of Your Head Mean?
A throbbing headache on the right side of your head can be unsettling and may have underlying causes you might not be aware ...
Future Market Insights
5 小时
Global CGRP Inhibitors Market Set to Surge with a Projected CAGR of 12.4%, Reaching USD 10. ...
CGRP Inhibitors Market. The global CGRP inhibitors market is poised for robust growth, with its valuation expected to rise ...
Healthshots on MSN
6 小时
Topiramate for weight loss: Can this antiepileptic drug help you shed kilos?
Ozempic, used for treating diabetes, is quite popular among people who want to lose weight. But it is not the only weight loss drug that may show positive results. Your doctor may also recommend ...
Targeted Oncology
2 天
Roundtable Roundup: Lung Cancer Molecular Testing and ALK-Targeted Treatment
In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options ...
BlackDoctor
3 天
7 Herbal Teas That Reduce the Pain of Migraines
Let’s get into some of the therapeutic properties of these herbal teas, how they work, and what they can do for those nagging headaches.
thecardiologyadvisor.com
3 天
Examining the Link Between Migraine and Stroke and MI
The association between hospital-diagnosed migraine and increased risks to cardiovascular health cannot be attributed to NSAID use.
3 天
Ozempic, Wegovy and other new drugs are selected for Medicare's price negotiations
WASHINGTON (AP) — Popular weight loss drugs like Ozempic and Wegovy have been added to Medicare’s list of medications that ...
Targeted Oncology
4 天
FDA Approves Axatilimab for Chronic GVHD in New Vial Sizes
Axatilimab has gained FDA approval in 9 mg and 22 mg vials, expanding treatment options for patients with chronic GVHD after ...
Endocrinology Advisor
5 天
Gemtesa Approved for Men With OAB Symptoms Receiving BPH Treatment
The FDA has approved Gemtesa® for men with overactive bladder symptoms receiving pharmacological therapy for BPH.
Acupuncture Today
5 天
An Auricular Point for Migraines: New Research
Medication remains a mainstay treatment option, making nondrug alternatives critical to safer practices. New research ...
5 天
Teen's face went numb at the start of a calculus exam. Another migraine? No. A stroke.
Because Maddy had a history of migraines that caused numbness and tingling in her extremities, they figured she was suffering ...
Rolling Out
6 天
New migraine drug cuts rebound headache risk
New study reveals how Atogepant prevents migraines and reduces rebound headaches in chronic sufferers, offering hope for ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈